Publications by authors named "M Halladjian"

Claim this Profile
R
Reference-free RNA profiling predicts triple negative breast cancer chemoresistance to neoadjuvant treatment.
Nouritza Torossian, Marc Gabriel, Panagiotis Papoutsoglou, Dominika Foretek, Camille Brochard, Maral Halladjian

NAR Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.
D M Filippini, B Cabarrou, C Dupain, M Halladjian, E Coquan

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of pembrolizumab and vorinostat combination in patients with recurrent and/or metastatic squamous cell carcinomas: a phase 2 basket trial.
Edith Borcoman, Bastien Cabarrou, Miguel Francisco, Frédéric Bigot, François Ghiringhelli, Maral Halladjian

Nat Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering molecular relapse and intra-tumor heterogeneity in non-metastatic resectable head and neck squamous cell carcinoma using circulating tumor DNA.
Grégoire Marret, Constance Lamy, Sophie Vacher, Luc Cabel, Mathieu Séné, Maral Halladjian

Oral Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer evaluation of tumor-infiltrating lymphocytes and programmed cell death protein ligand-1 in metastatic biopsies and matched primary tumors.
Zakhia El Beaino, Célia Dupain, Grégoire Marret, Xavier Paoletti, Laëtitia Fuhrmann, Maral Halladjian

J Pathol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis